rofecoxib has been researched along with Thromboembolism, Venous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goy, J | 1 |
| Paikin, J | 1 |
| Crowther, M | 1 |
| Lee, T | 1 |
| Lu, N | 1 |
| Felson, DT | 1 |
| Choi, HK | 1 |
| Dalal, DS | 1 |
| Zhang, Y | 1 |
| Dubreuil, M | 1 |
1 review available for rofecoxib and Thromboembolism, Venous
| Article | Year |
|---|---|
Rofecoxib does not appear to increase the risk of venous thromboembolism: a systematic review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Humans; Lactones; Risk Factors | 2014 |
1 other study available for rofecoxib and Thromboembolism, Venous
| Article | Year |
|---|---|
Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cyclooxygenase 2 Inhibitors; Di | 2016 |